{ "Comparing Imaging Techniques for Metastatic Cancer", "This study is comparing two ways to image metastatic cancer: Whole Body Magnetic Resonance Imaging with Diffusion-Weighted Imaging (WB-MRI-DWI) and Positron Emission Tomography combined with Magnetic resonance imaging (PET/MRI) using Fluorodeoxyglucose F18. We want to see how well WB-MRI-DWI detects cancer compared to the standard PET/MRI. You might be able to join if you are at least 18 years old, have metastatic cancer, and are already scheduled for a non-FDG PET imaging study. The main goal is to see what proportion of cancer spots are found by each imaging method. This study is currently recruiting about 30 participants.", "design": "This is a single-arm study, meaning all participants receive the same intervention. It aims to enroll about 30 participants.", "commitments": "You will have one imaging session using WB-MRI-DWI concurrently with FDG PET/MRI. This will happen within 60 days of another non-FDG PET scan you are already scheduled for. There might be an optional follow-up PET/MRI within six months.", "compensation": "Not stated in the trial record.", "follow_up": "Your medical records will be reviewed for up to two years after your imaging session.", }

Study design

Not specified.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.